ABSTRACT The objective of this in vivo experiment was to evaluate the influence of arabinoxylooligosaccharides (AXOS) on shedding and colonization of Salmonella Enteritidis in broilers. Arabinoxylooligosaccharides, which are oligosaccharides derived from arabinoxylans by partial hydrolysis, have a beneficial effect on feed conversion ratios when added to broiler diets. Additionally, AXOS have been shown to promote the growth of bifidobacteria in the ceco-colonic compartment of the gastrointestinal tract. To investigate the impact of AXOS on colonization of broilers with Salmonella, 224 one-day-old chicks were divided into 4 groups and given either unsupplemented feed or feed supplemented with 0.2% AXOS-3-0.25, 0.2% AXOS-9-0.25, or 0.4% AXOS-9-0.25 throughout the experiment. The AXOS-3-0.25 and AXOS-9-0.25 both have an arabinose-to-xylose ratio of 0.25 and have an average degree of polymerization of 3 and 9, respectively. At 14 d posthatch, each animal was orally inoculated with 2.5 × 10 9 cfu of Salmonella Enteritidis. Cloacal swabs, taken at regular times, showed a significant reduction of Salmonella presence in the group given 0.4% AXOS-9-0.25 compared with the control group. This reduction was observed in the 1-to 11-d postinfection period. Colonization of the ceca as well as the translocation of Salmonella to the spleen was significantly reduced at 3 and 7 d postinfection in the 0.4% AXOS-9-0.25 group. A similar, although more moderate, decrease in colonization was observed in the group given 0.2% AXOS-9-0.25. It was concluded that dietary addition of AXOS provides dose-dependent protection against oral infections with Salmonella Enteritidis in poultry.
INTRODUCTION
Gastroenteritis is a significant problem in animal husbandry as well as in human medicine (Hall et al., 2005) . Gastroenteritis in humans can be caused by foodborne pathogens, such as bacterial species belonging to the Salmonella, Campylobacter, Escherichia, Listeria, Clostridium, or Shigella genera. In animals, gastrointestinal infections can be controlled by using antimicrobial agents, but their use is strongly discouraged in many countries because of the growing awareness of antimicrobial-resistance problems. Alternative treatments include the use of dietary supplements, such as short-or medium-chain organic acids (Van Immerseel et al., 2002 ; manno-oligosaccharides, which interfere with mucosal attachment of pathogens (Spring et al., 2000) ; fructan-based oligosaccharides, which stimulate beneficial gut microbiota (Flickinger et al., 2003) ; or inoculation of the animals with competitiveexclusion microbiota (Stavric and D'Aoust, 1993) .
There is a need to extend the range of preventive and therapeutic treatment methods, especially because some of the proposed control agents do not yield consistent results. For instance, inulin and oligofructose have been reported to decrease the incidence of systemic infection by Salmonella Typhimurium and Listeria monocytogenes in mice (Buddington et al., 2002) , whereas in rats they increased the levels of Salmonella Enteritidis in the gut and promoted systemic translocation (Ten Bruggencate et al., 2003 . Likewise, inclusion of an oligofructose from Jerusalem artichokes in chicken diets promoted colonization of chicken ceca by Salmonella Typhimurium, whereas oligofructose from chicory roots had the opposite effect (Chambers et al., 1997) .
Arabinoxylans are polysaccharides that occur in the cell wall of most monocotyledonous plant species, and are therefore abundantly present in cereal-based diets. They consist of a main chain of β-1,4-linked dxylopyranosyl units to which O-2-or O-3-α-l-arabinofuranosyl units are linked, together with minor substituents such as α-(methyl)glucuronyl, acetyl, feruoyl, or the p-coumaryl groups (Gruppen et al., 1992; Izydorczyk and Biliaderis, 1995) . Arabinoxylooligosaccharides (AXOS) are oligosaccharides derived by partial hydrolysis of arabinoxylan. They have been demonstrated to improve feed conversion when added to the diets of animals (Courtin et al., 2008a) , whereas uncleaved arabinoxylan is well known to hamper efficient feed utilization (Choct and Annison, 1992) . Arabinoxylooligosaccharides have also been shown to stimulate the growth of beneficial microflora components in the ceco-colonic compartment of the gastrointestinal tract (Yamada et al., 1993; Courtin et al., 2008a,b) , whereas arabinoxylans promote fermentation in the ileum (Choct et al., 1996) . The effect of dietary supplementation with arabinoxylans or AXOS on the shedding and colonization of Salmonella in broiler chickens has not yet been investigated. Control of Salmonella by using feed additives is, however, an important tool in Salmonella control in broilers, and additives beneficially affecting both performance and Salmonella colonization would be of interest. In the present study, the impact of dietary inclusion of AXOS on colonization of the ceca and internal organs of chickens by Salmonella Enteritidis was assessed.
MATERIALS AND METHODS

AXOS Preparations
Arabinoxylooligosaccharide-9-0.25 was prepared from wheat bran by extraction with a glycosyl hydrolase family (GHF) 11-endoxylanase (Grindamyl H640, Danisco, Copenhagen, Denmark) as described by Swennen et al. (2006) , except that the protease treatment of the bran was omitted. This preparation had a polymeric xylose and arabinose content of 61% on a DM basis and an arabinose-to-xylose ratio of 0.25. The average degree of polymerization of the AXOS was 9.
The AXOS-3-0.25 was prepared by enzymatic extraction from wheat bran as described previously by Swennen et al. (2006) , except that the xylanase treatment was performed for 10 h at 50°C with the GHF 11-xylanase (Grindamyl H640, Danisco) at 1.2 U/g of destarched and deproteinized wheat bran, and for another 10 h at 50°C after addition of a GHF 10-xylanase (Shearzyme 500L, Novozymes, Bagsvaerd, Denmark) at 21 U/g of destarched and deproteinized wheat bran. This preparation had a polymeric xylose and arabinose content of 81% on a DM basis, an arabinose-to-xylose ratio of 0.25, and an average degree of polymerization of 3.
Feed Composition
The control ration was a wheat-corn-soybean diet (Table 1) without addition of AXOS. The 0.2% AXOS-3-0.25 diet was the control ration, to which 0.25% (wt/ wt) of AXOS-3-0.25 (which corresponds to 0.2% AXOS content after correction for purity) was added. The 0.2% AXOS-9-0.25 diet was the control ration, with 0.33% (wt/wt) AXOS-9-0.25, corresponding to a 0.2% AXOS content after correction for purity. Finally, the 0.4% AXOS-9-0.25 diet consisted of the control ration to which 0.66% (wt/wt) AXOS-9-0.25 was added, corresponding to 0.4% AXOS content after correction for purity.
Salmonella Strain
Salmonella Enteritidis strain SE147, a well-characterized streptomycin-resistant strain isolated from a poultry farm (Methner et al., 1995) , was used in this experiment. The strain was grown for 6 h in Luria-Bertani medium (Sigma, St. Louis, MO), after which the number of cfu per milligram was determined by plating 10-fold dilutions of the bacterial suspension on brilliant green agar (BGA, Oxoid, Basingstoke, UK) containing 100 µg/mL of streptomycin (Sigma, St. Louis, MO). The bacterial suspension was stored at 4°C during plate counting and was diluted in PBS to obtain the desired infection dose. 
In Vivo Trial
A total of 224 newly hatched chickens (Ross breed) were randomly divided into 4 groups of 56 chickens each. Each group was housed under the same conditions, but in different isolation units. All chicks had ad libitum access to water and feed. At 3 d posthatch, all chicks were orally vaccinated against coccidiosis (Paracox-5, Schering-Plough Animal Health, Brussels, Belgium) and at 14 d posthatch, they were orally inoculated with 2.5 × 10 9 cfu of Salmonella Enteritidis per bird. Cloacal swabs of all animals were taken on the day of infection and at 1, 3, 7, 11, 15, 19 , and 23 days postinfection (dpi). At 1, 3, 7, 11, 15, 19, and 23 dpi, 8 birds per group were killed and samples of cecum and spleen were taken for bacteriological analysis. The experiment was approved by the ethical committee of the Faculty of Veterinary Medicine, Ghent University.
Bacteriological Analysis
Cloacal swabs were plated on BGA plates containing 100 µg/mL of streptomycin. When samples were negative after direct inoculation, they were preenriched overnight at 37°C in buffered peptone water (Oxoid, Basingstoke, UK), after which samples were enriched by addition of 1 mL of this suspension to 9 mL of brilliant green tetrathionate broth (Oxoid). After an overnight incubation, a drop of this suspension was plated on BGA containing 100 µg/mL of streptomycin.
For quantitative analysis, samples of ceca and spleen were homogenized in 10 vol of buffered peptone water, and 10-fold dilutions were made in PBS. For each dilution, 6 × 20 μL was inoculated on BGA containing 100 µg/mL streptomycin. After an overnight incubation, the number of cfu per gram of tissue was determined. Samples that were negative after titration were preenriched and enriched as described above. Samples that were Salmonella negative after titration but positive after enrichment were assumed to contain 0.5 × 10 1 cfu/g of tissue. Samples that were still negative after enrichment were assumed to have 0 cfu/g of tissue.
Statistical Analysis
The SPSS 15.0 software (SPSS Inc., Chicago, IL) was used for statistical analysis. Data sets on Salmonella counts were analyzed by multivariate ANOVA, with days after inoculation and treatment group as independent variables, using the Scheffé error protection for intervariable comparisons. The nonparametric KruskalWallis test was used to check for intertreatment effects on Salmonella scores or Salmonella counts at each time, and when intertreatment effects were detected (P < 0.05), the nonparametric Mann-Whitney test was used to determine significant differences between the control and each of the treatment groups. Data sets on percentages of Salmonella-positive swabs were analyzed by means of logistic regression with days after inoculation and treatment group as independent variables. The Cochran-Q test was used to check for intertreatment effects on percentages of Salmonella-positive swabs at each time, and when intertreatment effects were detected (P < 0.05), the McNemar change test was used to determine significant differences between the control group and each of the treatment groups.
RESULTS
The cloacal swabs, taken on the day of inoculation before the artificial infection, revealed no presence of Salmonella, showing that the animals were free of this pathogen at the onset of the experiment. More than 80% of the cloacal swabs taken in the control group were positive for Salmonella during the first 11 dpi after direct plating. From 15 dpi onward, the percentage of positive swabs declined steadily (Figure 1 ). Over the whole observation period, the 0.4% AXOS-9-0.25 group had a (P < 0.01) lower frequency of positive cloaca swabs in comparison with the control group. When looking at the comparison of the groups at the individual time points, a lower frequency of positive cases was seen at 1, 3, and 11 dpi, but not at 7 dpi. A similar lower frequency in Salmonella shedding was noticed in the group that was given 0.2% AXOS-9-0.25. Compared with the control group, this reduction was statistically significant at 3 and 11 dpi. The group that was given 0.2% AXOS-3-0.25 showed a significant reduction in shedding only at 11 dpi.
The mean log Salmonella cfu per gram of cecal content of the 0.4% AXOS-9-0.25 group was lower compared with the control group (P < 0.01) when evaluated over the whole observation period. When groups were compared on the individual observation days, significant differences were observed only at 3 (P < 0.05) and 7 dpi (P < 0.01; Figure 2 ). At 7 dpi, the difference in cecal Salmonella counts between the 0.4% AXOS-9-0.25 group and the control group was 2 log units. For the 0.2% AXOS-9-0.25 group, a significant reduction of more than 1 log unit was also observed (P < 0.05) at this time. In the 0.2% AXOS-3-0.25 group, the reduction was not significant.
The extent of Salmonella translocation to internal organs was assessed by measuring the Salmonella levels in spleen at different times after infection ( Figure  3) . During the 1-to 11-dpi period, the spleens were less colonized by Salmonella in all AXOS-treated groups relative to the control group. When the whole observation period was analyzed, a significantly lower level of Salmonella was found in the 0.2% AXOS-9-0.25 and 0.4% AXOS-9-0.25 groups compared with the control group. Univariate analysis on each individual observation day showed that the reduction was significant for the 0.4% AXOS-9-0.25 group at 3 (P < 0.05) and 7 (P < 0.01) dpi and for the 0.2% AXOS-9-0.25 group at 7 (P < 0.01) dpi. A trend for reduced colonization was detected for the 0.2% AXOS-3-0.25 group (P = 0.1) at 7 dpi.
DISCUSSION
There is a need for products that control Salmonella shedding and colonization in broilers. Indeed, the prevalence of Salmonella in broiler flocks is still high. A Salmonella baseline study carried out by the European Food Safety Authority showed that the percentage Salmonella-positive broiler flocks in the European Union was 23.7% in 2005 (European Food Safety Authority, 2007). In the United States, data on Salmonella Enteritidis in broiler chicken carcass rinses collected from 2000 through 2005 showed that the annual number of isolates increased by more than 4-fold and that the proportion of establishments with Salmonella Enteritidispositive rinses increased by nearly 3-fold (Altekruse et al., 2006) . Measures postharvest are of importance to reduce the contamination of carcasses, but measures at the primary production site are still necessary to pre- Figure 1 . Effects of 0.2% arabinoxylooligosaccharide (AXOS)-3-0.25, 0.2% AXOS-9-0.25, or 0.4% AXOS-9-0.25 in the diet on the percentage of Salmonella-positive cloacal swabs at different times after inoculation with Salmonella Enteritidis, measured after direct plating of the swabs. For a given time, the values marked with a symbol above the bars are significantly different from the control group according to the Cochran-Q test (*P < 0.05; **P < 0.01; ***P < 0.001). vent transmission of Salmonella strains to the slaughterhouse. Although hygienic practices are important to avoid the introduction of Salmonella on the farm or reduce infection pressure when Salmonella is present, these practices do not sufficiently reduce Salmonella contamination on farm. Vaccination of the broiler parent flocks can be used to decrease the susceptibility of the offspring (Methner and Steinbach, 1997) . Currently, however, Salmonella-inhibiting feed additives are the most widely used method to control Salmonella in broilers. Although many products are on the market, including short-chain fatty acids and prebiotics, the anti-Salmonella activity of many of these products has not been thoroughly investigated (Van Immerseel et al., 2002) . Products that beneficially affect performance while having anti-Salmonella activity are of interest, because one of the main concerns of the farmers is that meat production is not only safe, but also efficient (i.e., high growth level with a favorable feed conversion ratio). Especially in the European Union, where antimicrobial growth promoters have been banned since 2006, optimal performance has become an important issue. Arabinoxylooligosaccharides derived from wheat bran have been shown to have beneficial effects on the feed utilization efficiency in broilers (Courtin et al., 2008a) . In the present study, we showed that AXOS have a protective effect against intestinal colonization and systemic translocation of Salmonella. This protection seems to be dose-dependent, because the level of protection for all examined tissues was greater in the animals receiving 0.4% AXOS-9-0.25 compared with those receiving 0.2% of AXOS-9-0.25. Furthermore, the average chain length appears to play a role, because in general, less Salmonella colonization and translocation were observed with 0.2% AXOS-9-0.25 than with the same dose of AXOS-3-0.25.
Different hypotheses can be put forward concerning the reason for the protective effect of AXOS against Salmonella shedding and colonization in broilers. It can be speculated that the increased number of bifidobacteria in the cecum of chickens fed a diet containing AXOS may be able to decrease the count of the potentially detrimental Salmonella. Indeed, AXOS was shown to significantly increase the number of bifidobacteria in the ceca of broilers (Courtin et al., 2008a,b) . Bifidobacteria are known to stimulate butyric acid production in the ceca as a result stimulating the growth of strictly anaerobic bacterial species (Belenguer et al., 2006) . Butyric acid, in turn, has been shown to decrease the invasion of Salmonella in gut epithelial cells and colonization of the ceca and internal organs in young chickens, possibly mediated by a specific effect of butyric acid on invasion gene expression (Van Immerseel et al., 2004 Gantois et al., 2006) . Alternatively, it is possible that AXOS affects the intestinal immune responses, as has been observed for other prebiotics in experiments with animals (Schley and Field, 2002; Watzl et al., 2005) . These hypotheses need to be investigated further.
In conclusion, dietary addition of AXOS can potentially provide dose-dependent protection against shedding and colonization of broilers with Salmonella. Ara- binoxylooligosaccharides can thus be added to the list of potential control products that can be used as part of a Salmonella control program for broilers.
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